Amgen, Inc. (AMGN)
330.41
+0.38
(+0.12%)
USD |
NASDAQ |
Jan 16, 16:00
330.85
+0.44
(+0.13%)
After-Hours: 20:00
Amgen Market Cap: 177.92B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 154.97B |
| Johnson & Johnson | 526.82B |
| Eli Lilly & Co. | 929.39B |
| Merck & Co., Inc. | 270.12B |
| Regeneron Pharmaceuticals, Inc. | 77.04B |
Market Cap Related Metrics
| PE Ratio | 25.54 |
| PS Ratio | 4.985 |
| PEG Ratio | 0.3892 |
| Price to Book Value | 18.50 |
| Price to Free Cash Flow | 15.51 |
| Price | 330.41 |
| Earnings Yield | 3.91% |
| PEGY Ratio | 0.3729 |
| Operating PE Ratio | 17.45 |
| Normalized PE Ratio | 22.02 |